Novo Nordisk (NYSE:NVO) is back in focus after recent share price moves, with the stock up 3.0% over the past week and 9.5% over the past month, even as the past 3 months show an 11.2% decline.

See our latest analysis for Novo Nordisk.

At a share price of $52.39, Novo Nordisk has seen near term momentum pick up, with a 30 day share price return of 9.47%. However, the 1 year total shareholder return of 37.16% decline shows longer term pressure and suggests sentiment has recently shifted rather than steadily building.

If Novo Nordisk has put healthcare back on your radar, it could be a useful moment to scan other opportunities among healthcare stocks and see how they compare on growth, risk and valuation.

So with Novo Nordisk trading at…